Richard Casey

1.2k total citations
41 papers, 721 citations indexed

About

Richard Casey is a scholar working on Urology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Richard Casey has authored 41 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Urology, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Psychiatry and Mental health. Recurrent topics in Richard Casey's work include Hormonal and reproductive studies (12 papers), Urinary Bladder and Prostate Research (12 papers) and Sexual function and dysfunction studies (11 papers). Richard Casey is often cited by papers focused on Hormonal and reproductive studies (12 papers), Urinary Bladder and Prostate Research (12 papers) and Sexual function and dysfunction studies (11 papers). Richard Casey collaborates with scholars based in Canada, United States and Australia. Richard Casey's co-authors include Gerald Brock, Jack Barkin, J. Curtis Nickel, Peter Pommerville, Jean D. Wilson, Joe Downey, Joseph Zadra, Janet Clark, Gary Steinhoff and Bernard Goldfarb and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

Richard Casey

39 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Casey Canada 15 309 234 213 198 161 41 721
Theodor Klotz Germany 16 247 0.8× 212 0.9× 274 1.3× 164 0.8× 102 0.6× 36 729
Robert Pickard United Kingdom 11 408 1.3× 186 0.8× 205 1.0× 253 1.3× 230 1.4× 29 664
Kweon Sik Min South Korea 15 408 1.3× 294 1.3× 370 1.7× 101 0.5× 271 1.7× 34 767
Jintetsu Soh Japan 15 207 0.7× 116 0.5× 112 0.5× 141 0.7× 98 0.6× 36 563
Kostis Gyftopoulos Greece 18 505 1.6× 178 0.8× 187 0.9× 243 1.2× 349 2.2× 48 985
Enrico Spera Italy 12 178 0.6× 148 0.6× 184 0.9× 167 0.8× 114 0.7× 19 512
Ali Memiş Türkiye 13 429 1.4× 233 1.0× 81 0.4× 289 1.5× 189 1.2× 56 755
Carlos Ary Vargas Souto Brazil 13 215 0.7× 332 1.4× 353 1.7× 98 0.5× 53 0.3× 26 612
Ernst Ulbrich Germany 13 347 1.1× 471 2.0× 652 3.1× 63 0.3× 63 0.4× 24 824
Peter Pommerville Canada 20 732 2.4× 518 2.2× 613 2.9× 339 1.7× 405 2.5× 48 1.4k

Countries citing papers authored by Richard Casey

Since Specialization
Citations

This map shows the geographic impact of Richard Casey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Casey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Casey more than expected).

Fields of papers citing papers by Richard Casey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Casey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Casey. The network helps show where Richard Casey may publish in the future.

Co-authorship network of co-authors of Richard Casey

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Casey. A scholar is included among the top collaborators of Richard Casey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Casey. Richard Casey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gotto, Geoffrey, Darrel Drachenberg, Joseph L. Chin, et al.. (2020). Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Canadian Urological Association Journal. 14(12). E616–E620. 6 indexed citations
2.
Casey, Richard. (2018). Medical urologists…no longer an oxymoron. Canadian Urological Association Journal. 13(2). 71–72. 1 indexed citations
3.
Gotto, Geoffrey, Vincent Fradet, Darrel Drachenberg, et al.. (2018). Real-world evidence in patient-related outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate plus prednisone (AA+P).. Journal of Clinical Oncology. 36(6_suppl). 196–196. 3 indexed citations
4.
Tanguay, Simon, Gerald Brock, Richard Casey, et al.. (2013). Diagnosis and management of benign prostatic hyperplasia in primary care. Canadian Urological Association Journal. 3(3-S2). 92–92. 25 indexed citations
5.
Casey, Richard. (2013). The use of hormonal therapy in “andropause”: the con side. Canadian Urological Association Journal. 2(1). 47–47. 3 indexed citations
6.
Morales, Álvaro, et al.. (2007). Adding to the controversy: Pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. The Aging Male. 10(2). 57–65. 40 indexed citations
7.
Gleave, Martin, J. Qian, Joseph L. Chin, et al.. (2006). The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer—results from a 4-month pre-radical prostatectomy study. The Prostate. 66(15). 1674–1685. 63 indexed citations
8.
9.
10.
Casey, Richard, et al.. (2006). Zoledronic acid reduces bone loss in men with prostate cancer receiving goserelin. Bone. 38(3). 71–71. 2 indexed citations
11.
Saad, Fred, et al.. (2005). Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin.. PubMed. 12(4). 2745–54. 3 indexed citations
12.
Torrance, George W., et al.. (2004). Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function. Quality of Life Research. 13(2). 349–359. 27 indexed citations
13.
Greiner, Jack V., Thomas K. Mundorf, Harvey Dubiner, et al.. (2003). Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. American Journal of Ophthalmology. 136(6). 1097–1105. 26 indexed citations
14.
Nickel, J. Curtis, Joe Downey, Janet Clark, et al.. (2003). Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 62(4). 614–617. 132 indexed citations
15.
Lording, Douglas, Guangwei Li, Jang‐Joo Kim, et al.. (2001). Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. International Journal of Impotence Research. 13(6). 317–321. 43 indexed citations
16.
17.
Casey, Richard, et al.. (1998). Alveolar Macrophage Release of Tumor Necrosis Factor‐α in Chronic Alcoholics without Liver Disease. Alcoholism Clinical and Experimental Research. 22(3). 567–572. 40 indexed citations
18.
Elhilali, Mostafa, Ernest W. Ramsey, Jack Barkin, et al.. (1996). A multicenter, randomized, double-blind, placebocontrolled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia. Urology. 47(3). 335–342. 45 indexed citations
19.
Waller, Julian A. & Richard Casey. (1990). Teaching about substance abuse in medical school. British Journal of Addiction. 85(11). 1451–1455. 9 indexed citations
20.
Casey, Richard & Jean D. Wilson. (1984). Antiestrogenic Action of Dihydrotestosterone in Mouse Breast. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodor Klotz Breakdown of academic impact, for papers by Robert Pickard Breakdown of academic impact, for papers by Kweon Sik Min Breakdown of academic impact, for papers by Jintetsu Soh Breakdown of academic impact, for papers by Kostis Gyftopoulos Breakdown of academic impact, for papers by Enrico Spera Breakdown of academic impact, for papers by Ali Memiş Breakdown of academic impact, for papers by Carlos Ary Vargas Souto Breakdown of academic impact, for papers by Ernst Ulbrich Breakdown of academic impact, for papers by Peter Pommerville
Rankless by CCL
2026